It was found to promote cellular senescence in breast cancer [36], to reduce the expression of MMP-9 and limit the invasion of human glioblastoma and breast cancer cell lines via inhibiting the Ras/Raf-1/ERK/AP-1 pathway [24]. The gene discussed is MMP9; the disease is breast carcinoma.